Carcinoma, Signet Ring Cell
2 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Biopsy Procedure + Biospecimen Collection + Computed Tomography + Laboratory Biomarker Analysis + Positron Emission Mammography + TALIMOGENE LAHERPAREPVEC + NIVOLUMAB for carcinoma, signet ring cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| FAPi-46 GA-68 for carcinoma, signet ring cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |